Broadcom Stock AVGO Q3 Preview: Can AI Revenue Beat Restore Gains?
Generated byAinvest Street BuzzReviewed byThe Newsroom
Wednesday, Sep 2, 2026 11:09 am ET1min read
AVGO--
Aime Summary
- Broadcom is scheduled to report Q3 fiscal 2026 earnings on September 2, with consensus expecting $29.4 billion in revenue and $3.22 in EPS.
- AI semiconductor revenue is projected to surge over 200% year-over-year to $16 billion, accounting for more than half of total sales.
Investors are heavily focused on whether management will raise its FY27 AI revenue guidance to validate the $100 billion+ target.
The stock has fallen roughly 23% from its June highs due to margin compression concerns and a lackluster forward outlook.
- Wall Street maintains a Strong Buy consensus, with analysts targeting an average price of $511.88.
Stay ahead with real-time Wall Street scoops.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet